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Stool sampling and DnA isolation 
kits affect DNA quality and 
bacterial composition following 16S 
rRNA gene sequencing using MiSeq 
Illumina platform
Petra Videnska1, Kristyna Smerkova  1, Barbora Zwinsova1, Vlad popovici1, 
Lenka Micenkova1, Karel Sedlar2 & eva Budinska1
Many studies correlate changes in human gut microbiome with the onset of various diseases, mostly 
by 16S rRNA gene sequencing. Setting up the optimal sampling and DNA isolation procedures is 
crucial for robustness and reproducibility of the results. We performed a systematic comparison of 
several sampling and DNA isolation kits, quantified their effect on bacterial gDNA quality and the 
bacterial composition estimates at all taxonomic levels. Sixteen volunteers tested three sampling 
kits. All samples were consequently processed by two DNA isolation kits. We found that the choice 
of both stool sampling and DNA isolation kits have an effect on bacterial composition with respect to 
Gram-positivity, however the isolation kit had a stronger effect than the sampling kit. The proportion 
of bacteria affected by isolation and sampling kits was larger at higher taxa levels compared to lower 
taxa levels. The PowerLyzer PowerSoil DNA Isolation Kit outperformed the QIAamp DNA Stool Mini Kit 
mainly due to better lysis of Gram-positive bacteria while keeping the values of all the other assessed 
parameters within a reasonable range. The presented effects need to be taken into account when 
comparing results across multiple studies or computing ratios between Gram-positive and Gram-
negative bacteria.
The gut microbiome plays a key role in shaping human health and has been the subject of an increasing num-
ber of studies in the context of disease development, diagnostics and treatment. Important progress has been 
made especially in investigating uncultured bacteria, which constitute the main part of the gut microbiome 
and were previously difficult to characterize with standard techniques such as cloning, Sanger sequencing or 
Denaturing Gradient Gel Electrophoresis (DGGE)1,2. Next generation sequencing (NGS) provides new and more 
detailed means to study the human microbiome and helps uncovering its impact on the human immune system 
development3–5, or on the development of chronic diseases6,7. However, human microbiome is very dynamic 
and can change rapidly in response to many factors such as diet, antibiotic use, lifestyle or environment8–16. 
Many diseases were associated with a phenomenon called dysbiosis – microbial imbalance. Unfortunately, due 
to the huge microbiome variability it is very difficult to define a normality baseline for an individual. To extract 
disease-relevant information and generate new or confirm existing biological hypotheses, large cohort microbi-
ome studies are needed. These studies face multiple challenges with the microbiome sampling. First, successful 
compliance of participants with the established protocol demands both motivation and an easy sampling proce-
dure. Especially, sampling of the stool at home can induce a “yuck effect” and positive education and uncompli-
cated sampling workflow can significantly decrease the number of study drop-outs17,18.
Another major problem is the large variability of methodological approaches employed by different micro-
biome studies. The final composition of bacteria as assessed by sequencing the 16S rRNA gene is influenced 
by many factors: sampling method19–22, sample storage conditions20,22–29, DNA extraction8,21,22,26,30–39, primers 
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targeting different parts of the 16S rRNA gene40,41 and data analysis42. All of these factors may lead to the mis-
interpretation of changes in the microbiome and thus hamper direct comparisons of results between individual 
studies43–45. These technical problems, along with an as yet unknown gut microbiome diversity in the healthy 
population, lead to challenges in the implementation of metagenomics into cohort studies and, in consequence, 
delay the translation of the knowledge to clinical practice.
Most studies focused on the technical factors influencing the assessment of bacterial composition often pro-
vide only a description of the observed differences on a limited number of samples, while the comparison of the 
effect sizes of these factors, or combination thereof remains unexplored. The effect of sampling was previously 
described with respect to storage conditions (such as temperatures20,23,26,28,29, periods at room temperature20,24 or 
a presence and type of stabilizer19,21,22,27,28). None of these studies reported on the volunteers’ compliance or the 
differences in preprocessing steps specific to different sampling kits. Multiple studies describe the effect of stool 
homogenization prior DNA extraction25,46, but they only report its overall effect on the interindividual variation, 
without quantifying this effect at different bacterial taxon levels.
The DNA extraction method was highlighted as a critical factor influencing the observed bacterial compo-
sition39,47. Commercially available extraction kits use different lysis procedures such as enzymatic, chemical or 
mechanical bacterial cell disruption methods. Generally, the combination of enzymatic and mechanical disrup-
tion is recommended as more effective in the lysis of Gram-positive bacteria8,22,26,34,35,37,39. However, these DNA 
extraction comparison studies are limited to a rather small number of individuals (from 2 to 9) and none of them 
compared the kits in terms of DNA yield and quality, presence of PCR inhibitors, the human to bacterial DNA 
ratio, the efficiency of Gram-positive bacteria cell wall lysis and the observed bacterial composition at different 
taxa levels all at once.
The aim of our study was therefore to perform systematic assessment of effect of sampling and DNA isolation 
kits and their combinations on a full range of parameters of bacterial DNA quality, bacterial diversity and com-
position, with respect to user acceptance.
Results
We analyzed stool samples from sixteen volunteers. Each volunteer collected the samples from the same stool 
sample using three different sampling kits (SK): a stool container (SK1); a flocked swab (SK2) and a cotton 
swab (SK3). The DNA was extracted using two isolation kits PowerLyzer PowerSoil DNA Isolation Kit (PS) and 
QIAamp DNA Stool Mini Kit (QS) (see Methods), totaling 96 samples for the analysis.
Evaluation of user acceptance of the sampling kits. The participants were asked to select the best and 
the worst kit based on their ease of manipulation including the time spent using it. All 16 volunteers selected the 
stool container as the easiest to use and 13 out of 16 (81.25%) volunteers indicated the flocked swab as the worst 
sampling kit. We believe that the manipulation with cotton and flocked swabs is uncomfortable due to the small 
size and the necessity to insert the swab stick back into the tube without touching the tube wall. On the contrary, 
the stool container is easy to manipulate even for people with reduced motoric skills. In addition, the flocked 
swab is designed for sampling of liquid samples and the solid stool samples do not adhere on its synthetic fibers.
The effect of sampling and DNA isolation kits on the bacterial gDNA quality. DNA yield, purity 
and integrity. Significantly higher DNA yields were obtained with the QS isolation kit, regardless of the sam-
pling kit used (q < 0.01) (Fig. 1, Supplementary Table S1). The median values of the A260/A280 ratio (the meas-
ure of purity of DNA) were well within the expected range (1.8–2) and did not differ significantly between the 
DNA isolation kits or between the sampling kits (Fig. 1, Supplementary Table S1).
The DNA integrity was determined using the GQN measure (on a scale from 1 to 10; low GQN indicates 
strongly degraded gDNA sample) and the proportion of short fragments (≤1500 bp; the larger the proportion 
the more degraded gDNA). We observed interaction effects of isolation and sampling kit for both DNA integrity 
measures. We found significantly lower proportion of short fragments when using the PS isolation kit (Fig. 1, 
Supplementary Table S1) and this difference was much larger when the stool container was used for sampling. 
There was no difference in GQN measure between the isolation kits when cotton or flocked swabs were used. 
However, for stool container samples, the QS kit provided much lower GQN values compared to the PS kit. These 
results point to worse DNA integrity for the QS isolation kit compared to the PS isolation kit mostly when stool 
container is used for sampling.
Presence of PCR inhibitors. The presence of PCR inhibitors in the samples decreases the sensitivity of the PCR 
reaction and even can lead to the impossibility of amplification of the selected region of 16S rRNA. It is usually 
measured by median efficiency values estimated from inhibition plots. Ideally, the efficiency should be 100%, 
meaning the template doubles in each cycle. Usually, the efficiency within 90–110% range is considered accept-
able, where lower efficiency is caused by non-optimal reagent concentration or lower enzyme quality, while higher 
efficiency values are caused by the presence of PCR inhibitors. In our data, the efficiency values ranged from 
96.7% to 114.0% (Fig. 1, Supplementary Table S2). In each of the isolation/sampling kit combinations, there were 
minimum two samples which exceeded the efficiency of 110%. The efficiency values of all isolation/sampling kit 
combinations, except for stool container samples after DNA isolation with the QS kit, were significantly increased 
compared to control samples without PCR inhibitors (efficiencymed = 94.7%). No difference in efficiency values 
was observed between the isolation kits. The samples from stool containers (regardless of the isolation kit used) 
contained less PCR inhibitors in comparison to all other sampling/DNA isolation kit combinations (significantly 
lower efficiency, Supplementary Table S2). We hypothesize that this sampling kit effect is due to the sample dilu-
tion step prior to the DNA isolation step.
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Human to bacterial DNA ratio. In all samples, the quantity of human DNA was lower than that of the bacterial 
DNA (ranging from 2947x to 221239x, median 29369x, see Fig. 1, Supplementary Table S2). No difference was 
found between sampling/isolation kit combinations in terms of human to bacterial DNA ratio, except for the 
increased ratio in the stool container compared to flocked swab samples after isolation with the QS kit (q = 0.03).
The effect of sampling and DNA isolation kits on bacterial diversity and composition. Bacterial 
diversity. In total, 96 stool samples were sequenced. The number of reads after quality filtering and removal of 
chimeras ranged from 27680 to 67809, with median of 46192. We assessed the bacterial diversity using the num-
ber of observed OTUs and the Chao 1 diversity metric (Fig. 1, Supplementary Table S1). Overall, both diversity 
measures were independent of the DNA yield in all sampling/DNA isolation kit combinations.
While there was no difference in Chao 1 measure between the isolation kits, the number of observed OTUs was 
significantly increased after isolation with the PS kit, but only for cotton swab samples (q-value = 0.029). When 
comparing diversity measures between the sampling kits within each isolation kit separately, the stool container 
resulted in significantly higher number of observed OTUs in both DNA isolation kits (Fig. 1, Supplementary 
Table S1). In addition, we observed significantly higher number of OTUs in flocked swab samples compared to 
cotton swab samples after DNA isolation with the PS kit (q-value = 0.04) and significantly lower number of OTUs 
in flocked swab samples compared to cotton swab samples after DNA isolation with the QS kit (q-value = 0.09). 
For the Chao 1 diversity metric, significant differences were found in stool container samples compared to flocked 
swab samples in both PS and QS isolation kits (q = 0.04 and q = 0.09, respectively).
Bacterial composition. We identified 12,948 OTUs belonging to 13 bacterial phyla.
In order to quantify the effect of the sampling and isolation kits on bacterial composition, we performed mixed 
linear regression on each taxon that passed the filtering criteria (maximum abundance across all samples ≥1%) at 
all the seven taxonomical levels (phylum, class, order, family, genus, species, OTUs) separately. Interestingly, the 
proportion of taxa significantly affected by isolation or sampling kit differed between taxonomical levels (Fig. 2). 
The choice of sampling or DNA isolation kit affected 100% of taxa at phylum, class and order levels, and had 
decreasing trend from family to OTU level. The effects of sampling and isolation kits on the ten most abundant 
taxa at different taxa levels are summarized in Table 1 (see Supplementary Tables S3–S8 for complete results), the 
composition of significantly affected families is shown in Fig. 3. Overall, the choice of the isolation kit affected the 
abundance of more taxa than the choice of the sampling kit. In most of the cases where the taxa was affected by 
both factors, the p-values associated with the effect of the isolation kit were smaller than those of the sampling kit, 
indicating a more significant contribution of isolation kit to the overall model.
We hypothesized that the observed effect of the isolation kit was a result of different efficiency of the 
kit-specific bacterial cell walls lysis procedure. In this case, one of the kits would be more successful in isolating 
Figure 1. Comparison of sample DNA quality and diversity using different sampling and isolation kits. 
(A) DNA yield and purity comparison. dthe samples were five times diluted prior the DNA extraction (see 
Methods); (B) DNA integrity comparison; (C) Presence of PCR inhibitors and human to bacterial DNA ratio 
comparison. Horizontal dotted line represents median efficiency value of the positive control; (D) Bacterial 
diversity comparison.
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Gram-positive (G+) bacterial species. The Table 2 shows the numbers of significantly affected G+ taxa in all taxo-
nomic levels and statistical pairwise comparison of their proportion after both isolation methods and all sampling 
methods. We found significantly higher proportions of G+ bacteria after the isolation using the PS kit at all the 
taxon levels. (96.4% to 100%, Table 2), compared to the QS isolation kit (G+ proportion varying from 0 to 44%). 
Similar observations were made for the effect of the sampling kit (Table 2), but this trend was not significant on 
any of the taxa levels except for the comparison of cotton swab (SK2) and stool container (SK1) on the genus level. 
We hypothesize that these differences are attributed to the dilution of the samples during the preprocessing steps 
specific to the stool container (see Methods for more details), resulting in lower sample density thus increasing 
the efficiency of the bead beating procedure. No difference in proportion of Gram-positive bacteria was found 
between flocked and cotton swabs. Figure 4 shows estimated effect sizes pairwise between the sampling kits on 
the genus level. Figure 5 visualizes bacteria with significant changes in abundance between isolation or sampling 
kits, with nodes colored according to Gram-positivity, where we can observe association of Gram-positive bac-
teria with the PS isolation kit.
Discussion
The gut microbiome seems to be crucial factor influencing human health and to date, a number of different 
diseases were correlated with microbiome dysbiosis. Understanding the true role of microbiome and fully com-
prehending its variability will require many cohort studies and, most probably, comparison of their results in 
large-scale meta-analyses. As with any other scientific domain, the incoherent methodological approaches con-
stitute an important obstacle for such comparisons44. In an attempt to elucidate some of the factors determining 
the success of such studies, we focused on the effects of sampling and DNA extraction methods on a number of 
relevant variables from DNA integrity to final bacterial composition at different taxa levels. For this purpose, we 
selected sampling and DNA isolation kits that are the most common and accessible and hence are probably the 
most relevant for majority of cohort studies.
Our group of sixteen healthy volunteers used three different sampling kits – stool container, flocked swabs 
and cotton swabs. Without exception, the stool container was indicated as the most acceptable by the volun-
teers. Moreover, stool in the container can be easily diluted, homogenized and aliquoted for different analyses. 
Unfortunately, the stool container is inconvenient for sampling diarrhea or baby stool. Importantly, as we discuss 
below, the pre-processing specific to stool container samples influences both DNA quality and bacterial compo-
sition and these effects seem to interact with the DNA isolation kit.
For measuring the effect of different DNA extraction procedures, we used PowerLyzer PowerSoil DNA 
Isolation Kit (PS) and QIAamp DNA Stool Mini Kit (QS).
While the PS kit cell-wall lysis procedure is based on combination of bead-beating step and enzymatic lysis, 
the standard protocol of the QS kit comprises only enzymatic lysis. Considering the fact that the beat-beating step 
leads to higher DNA yield and higher number of observed OTUs from difficult-to-lyse bacteria, we added the 
bead-beating step also into the QS protocol, as commonly recommended8,30,34,35,39.
DNA isolation by the QS kit resulted in significantly higher DNA yields compared to the PS kit (regardless of 
the sampling kit). Similar results were observed in other studies30,32. In agreement with previous studies30,35,37, we 
found no significant correlation between DNA yield and alpha diversity.
Figure 2. The proportion of taxa significantly affected by sampling or isolation kit at different taxonomical 
levels. Proportion of the tested taxa significantly affected by the sampling kit only (green), by the isolation 
kit only (dark yellow) and by both sampling and isolation kit (brick red). Grey indicates taxa not affected by 
sampling or isolation kit. The significance level was chosen at FDR < 10%, only taxa that met the selection 
criteria (maximum abundance >1%) were tested.
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Taxonomic level (# of all and 
significantly affected taxa)
Taxa (show ten most 
abundant)
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Sign of the estimated effect size of 



















Max >1% taxa: 6




Firmicutes 1.27E-15 4.43E-11 + − − + 68.3 G+
Bacteroidetes 3.42E-02 1.81E-02 − + + + 18.5 G−
Actinobacteria 3.67E-17 5.13E-04 + − − − 7.1 G+
Proteobacteria 5.05E-08 3.47E-04 − + + + 1.1 G−
Verrucomicrobia 1.69E-03 2.39E-03 − − − + 0.5 G−
Tenericutes 2.08E-03 4.05E-01 − − − − 0.1 G−
Class
All taxa: 30
Max >1% taxa: 12




F; Clostridia 2.66E-15 9.45E-12 + − − + 61.2 G+
B; Bacteroidia 1.02E-02 2.15E-02 − + + + 18.5 G−
A; Actinobacteria 5.80E-14 3.04E-04 + − − − 4.6 G+
F; Negativicutes 2.58E-15 3.52E-04 − − − − 2.9 G−/var
A; Coriobacteria 5.80E-14 4.09E-03 + − − − 2 G+
F; Erysipelotrichia 2.66E-15 8.57E-05 + − − + 1.8 G+
F; Bacilli 2.58E-15 3.61E-05 + − − + 1 G+
V; Verrucomicrobiae 1.94E-03 1.33E-06 − − − + 0.5 G−
P; Betaproteobacteria 2.14E-05 1.49E-09 − + + + 0.4 G−
P; Gammaproteobacteria 3.67E-07 7.22E-03 − − − + 0.2 G−
Order
All taxa: 49
Max >1% taxa: 13




F; Clostridiales 9.46E-13 1.37E-11 + − − + 61.2 G+
B; Bacteroidales 4.58E-03 1.69E-02 − + + + 18.5 G−
A; Bifidobacteriales 5.63E-12 2.30E-03 + − − − 4.5 G+
F; Selenomonadales 9.08E-17 2.42E-03 − − − + 2.9 G−/var
A; Coriobacteriales 5.73E-12 2.30E-02 + − − − 2 G+
F; Erysipelotrichales 3.05E-13 2.16E-04 + − − + 1.8 G+
F; Lactobacillales 3.05E-13 1.98E-04 + − − + 1 G+
V; Verrucomicrobiales 3.29E-04 1.22E-05 − − − + 0.5 G−
P; Burkholderiales 1.33E-05 1.70E-09 − + + + 0.4 G−
T; Mollicutes 1.04E-05 6.43E-05 − − − + 0.1 G−
Family
All taxa: 85
Max >1% taxa: 23




F; Ruminococcaceae 9.20E-01 6.81E-13 − + + + 27.1 G+
F; Lachnospiraceae 5.68E-20 1.60E-03 + + + + 25.3 G+
B; Bacteroidaceae 7.55E-03 1.35E-02 − + + + 10.2 G−
A; Bifidobacteriaceae 5.90E-11 6.87E-03 + + + + 4.5 G+
F; Veillonellaceae 1.90E-12 1.55E-04 − + + + 2.4 G+
A; Coriobacteriaceae 7.68E-11 4.62E-02 − + + + 2 G+
F; Erysipelotrichaceae 1.74E-12 8.08E-04 − + + + 1.8 G+
F; Christensenellaceae 8.43E-01 1.24E-08 − + + + 1.4 G−
B; Rikenellaceae 5.90E-11 7.24E-01 − + + + 1.3 G−
B; Porphyromonadaceae 5.57E-04 4.03E-03 − + + + 1.1 G−
Genus
All taxa: 277
Max >1% taxa: 82




B; Bacteroides 6.18E-03 1.54E-02 − + + + 10.2 G−
F; Faecalibacterium 1.37E-02 9.70E-05 + − − + 7.2 G+
F; Blautia 1.24E-24 1.05E-01 + − − + 5 G+
A; Bifidobacterium 1.48E-10 2.48E-02 + − − − 4.5 G+
F; Subdoligranulum 4.64E-03 3.18E-01 − − − + 3.7 G−
F; Pseudobutyrivibrio 9.63E-10 6.32E-01 + − − + 2.8 G−
F; Dialister 3.17E-09 5.86E-03 − − − + 2.2 G−
F; Roseburia 1.85E-02 4.95E-01 + − − + 1.5 G+
A; Collinsella 8.59E-05 3.91E-01 + + − − 1.4 G+
F,Christensenellaceae R-7 group 6.06E-01 1.50E-07 − − − − 1.4 G−
Table 1. Summary of taxa at all levels and detailed results for top 10 taxa significantly affected by sampling 
or DNA isolation kit. The significant q - values are shown in bold. SK1- stool container; SK2 – flocked swabs; 
SK3 - cotton swabs; PS – PowerLyzer PowerSoil DNA Isolation Kit; QS - QIAamp DNA Stool Mini Kit. All taxa 
– number of taxa found at the respective taxa level; Max >1% taxa – number of taxa that fulfilled the selection 
criteria for the analysis; Significantly affected taxa – the overall number of taxa at the respective taxa level 
affected by the isolation or sampling kit; Isolation only – number of taxa at the respective taxa level affected by 
the isolation kit only; Sampling only – number of taxa at the respective taxa level affected by the sampling kit 
only; Both – number of taxa at the respective taxa level affected by both sampling and isolation kit.
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On the other hand, the PS kit produced DNA of better integrity, even though in the PS protocol we applied 
more rigorous mechanical lysis (or higher speed of bead beating), which, according to the literature, should result 
in more degraded DNA48. We hypothesize that the observed differences might be caused by another factor, such 
as the type of the beads (0.1 mm glass in PS vs 0.1 mm zirconia in QS), the buffer composition, or the incubation 
temperature. Overall, for preparation of the shotgun libraries or sequencing using third generation of sequencers, 
we consider DNA integrity to be more important factor than the DNA yield, which favors PS kit over the QS kit.
To properly homogenize the samples from the stool container, we included a preprocessing procedure com-
prising five times dilution. This naturally resulted in lower yields of isolated DNA, but after adjustment for this 
dilution we obtained higher final DNA concentrations compared to undiluted stool samples from flocked and 
cotton swabs. It seems that the dilution step also affected the DNA integrity. Compared to the undiluted samples 
from flocked and cotton swabs, stool container samples resulted in less degraded DNA after isolation using the PS 
Figure 3. Distributions of relative abundances of significantly affected taxa at family level. Four graphs 
represent families divided according to third quartile of their abundance. Only taxa that passed the filtering 
criteria (maximum abundance >1%), significantly affected by isolation or sampling kit are shown. The colored 
squares below the graph indicate whether the family was affected significantly by the sampling kit only, the 
isolation kit only or both.





% of G+ 
phyla q-val
% of G+ 
classes q-val
% of G+ 
orders q-val
% of G+ 
families q-val % of G+ geni q-val
PS to QS










in QS 0% (0/4) 0% (0/6) 0% (0/7) 0% (0/12) 44.1% (15/34)
SK2 to SK1










in S2 0% (0/2) 0% (0/3) 0% (0/3) 0% (0/5) 44.4% (4/12)
SK3 to SK1










in S3 0% (0/2) 0% (0/3) 0% (0/3) 0% (0/5) 38.5% (5/13)
SK3 to SK2










in S2 50% (1/1) 100% (2/2) 100% (2/2) 66.7% (2/3) 80.0% (8/10)
Table 2. Results of statistical testing of the proportion of G+ bacteria between significantly more abundant 
taxa within the selected isolation or sampling kit (pairwise). The significant q – values are shown in bold. 
SK1- stool container; SK2 – flocked swabs; SK3 – cotton swabs; PS – PowerLyzer PowerSoil DNA Isolation Kit; 
QS – QIAamp DNA Stool Mini Kit. Sample groups – which pairwise comparison was performed; Signif. more 
abundant – in which group the taxa were significantly more abundant; % of G+ taxa – proportion of G+ in the 
significantly more abundant taxa within the respective group and level.
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kit and, in contrast, in more degraded DNA after isolation using the QS kit. Interestingly, two other independent 
studies, where different isolation kits were used, showed either a negative34 or a positive48 effect of sample dilution 
on the DNA integrity. This, together with our results leads us to conclude, that the effect of dilution step on DNA 
integrity is dependent on the isolation kit.
PCR inhibitors persisted in the DNA of the samples after isolation with both kits. Presence of PCR inhib-
itors could complicate the use of conventional molecular methods for the detection of low abundance or rare 
Figure 4. Comparison of sampling kits effects at genus level. Each column corresponds to a pair of sampling 
kits and each row corresponds to a specific bacteria genus. The values represent log fold changes of bacterial 
abundances (effect size) between the sampling kits, color coded from green (less abundant) to orange (more 
abundant). Only significantly affected taxa are shown.
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pathogenic microorganisms49,50. The dilution of stool container samples prior to processing has led to signifi-
cantly lower proportion of PCR inhibitors, hence for some applications, this approach might be preferred.
Both DNA extraction kits isolated preferentially bacterial DNA, independently on the sampling kit used and 
the amount of human DNA was negligible. From practical point of view, there is no superiority of any of the DNA 
isolation vs sampling kit combinations with respect to amount of residual human DNA. Some of the studies, how-
ever, use these kits to estimate the concentration of human DNA in stool samples as an indicator of inflammation 
that might predict onset of certain bowel diseases51–55. From this perspective, based on our results, we do not 
consider these kits eligible for human DNA quantification.
As for the alpha diversity, we observed increased number of OTUs after DNA isolation with the PS kit in all 
sampling kits, but the difference was significant only for cotton swab samples. We observed significant differences 
in number of OTUs between all sampling kits combinations, with the stool container resulting in the highest 
number of OTUs. We attribute the observed differences to higher effectivity of bead beating process in the less 
dense samples (the dilution preprocessing step used for the stool container). This is in contrast with the results of 
Santiago et al.34, who report no changes in alpha diversity after sample dilution. In that study, however, a different 
isolation kit was used, so the results are not directly comparable.
The final bacterial composition was more affected by the choice of the DNA isolation kit than by the choice 
of the sampling kit. The preference of the PS isolation kit for Gram-positive bacteria was confirmed by statistical 
testing on all taxa levels and we believe that it is a result of more effective lysis of the Gram-positive cell wall bac-
teria when using the PS kit, despite the additional bead-beating step we introduced into the QS protocol. This is 
in agreement with previously published results8,26. It has to be taken into account, that Gram staining not always 
corresponds with the cell wall structure (e.g. Pseudobutyrivibrio56 or Deinococcus57, which is for many bacteria 
unknown. The efficiency of the lysis procedure can be as well influenced by atypical composition of the cell wall, 
presence of S-layer or capsules. The bacterial cell wall type also plays a role in the sampling effect: in our study it 
was associated with the dilution preprocessing step of the stool container, although less significantly.
There is a common belief that the effect of the individual is the most influential on the final bacterial composi-
tion8,32. Indeed, many metagenomic studies are reporting differences between groups of interest at the OTU level, 
where the effect of isolation and sampling is less important, as we showed in this study. However, some hypothe-
ses are connecting particular disease with higher or lower bacterial abundance at the phylum or family level. An 
example is the commonly used Bacteroidetes/Firmicutes ratio58–64. Our results show, that this ratio is very depend-
ent on both the selected DNA isolation method and sampling kit (dilution step). In our study, the PS kit and the 
dilution step (stool container) led to significantly higher proportion of e.g. Firmicutes (G+) and Actinobacteria 
(G+) and significantly lower proportion of Proteobacteria (G−) and Bacteroidetes (G−).
Another example of the cell wall structure effect is the Gram-positive genus Blautia. Blautia is a common and 
highly prevalent bacteria in the gastrointestinal tract, which is connected with healthy gut, since it is an effective 
short-chain fatty acid producer65,66. Lower abundance of Blautia in the gut is associated with many diseases66–73. 
In our study, Blautia was bacteria the most significantly affected by DNA isolation (across all the taxonomic lev-
els). Similar observations were also described as the effect of isolation in other studies26,34.
The sampling kit (dilution effect) influenced most significantly the abundance of genus Sutterella, bacteria 
correlated with many diseases such as celiac diseases67, Down syndrome74, autism75 or irritable bowel syndrome76. 
Clearly, the dilution step represents an important batch effect, which raises a question, whether it is related only 
to the artificial dilution, or this effect could also be observed in diarrheic samples. The effect of stool consistency 
was described previously as an important factor12,77,78 influencing the bacterial composition, but this effect was 
Figure 5. Association of bacterial families significantly differentially abundant between different sampling and 
isolation kits. The strength of the edges is weighted by relative abundance of taxa between the different kits (the 
stronger the edge, the larger the difference). Color-coding of the edges highlights taxa belonging to the same 
community, as detected by network modularity (see Methods for details). Grey edges represent connections 
between different communities.
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not connected with effect of higher water content (dilution), rather with the transit time. As previously recom-
mended77, we also suggest to control for the stool consistency as a potential confounding factor to avoid the effect 
of sample water content in this kind of studies, especially if one of the illness symptoms is diarrhea.
Despite the fact that the significance of the sampling and isolation dependent batch effects is repeatedly 
reported, no systematic study of these effects was performed yet on samples from larger numbers of individuals. 
Efforts for standardization of laboratory practices in metagenomics have been made in large international pro-
jects such as Metagenomic Research Group (MGRG), Genomic Standard Consortium (GSC), The Microbiome 
Quality Control Project (MBQC) and International Human Microbiome Standards (IHMS). IHMS recommends 
a procedure for fecal sample DNA extraction, based on study of Costea et al., where 21 extraction protocols were 
compared, including protocols similar to ours – protocol 3 (with PowerLyzer PowerSoil DNA Isolation Kit) and 
11 (with QIAamp DNA Stool Mini Kit and bead beating step)39. They selected the protocol with QIAamp DNA 
Stool Mini Kit as the best choice for its accuracy and reproducibility. In contrast to our results, both protocol 3 
and 11, provide good lysis of Gram-positive bacteria, but protocol 3 was excluded for insufficient DNA quality. 
The main difference between the studies is that the Costea study was based on the results of whole metagenomics 
sequencing and only compared bacterial composition annotated at the species level.
All these above mentioned studies and our results confirm that meta-analytical studies are extremely challeng-
ing due to the many sources of batch effects that need to be accounted for. Incorporation of a standardized mock 
community to the sequencing workflow, followed by normalization of the results to these reference values could 
be solution in future. The increased cost per run and slightly more complex library preparation is a small price to 
pay for robustness, consistency and comparability of results.
Conclusions
We performed systematic study of effects of DNA isolation and sampling kit on DNA quality and bacterial com-
position based on sequencing of gene for 16S rRNA on a the largest number of individuals to day (96 samples 
from 16 individuals).
We found significant effect of both DNA isolation and sampling kits on DNA purity, DNA integrity, alpha diversity 
and bacterial composition. Overall, the DNA isolation effect was stronger than that of the sampling kit. Interestingly 
the proportion of taxa affected by isolation or sampling was decreasing with decreasing taxonomical level.
We confirmed previously reported effect of DNA isolation kit on bacterial composition due to bacte-
rial cell wall structure, namely the better efficacy of The PowerLyzer PowerSoil DNA Isolation Kit in lysis of 
Gram-positive bacteria. In addition, we report that the dilution pre-processing step of the stool container samples 
favored Gram-positive bacteria, although mostly at the genus level.
Both the choice of isolation and sampling kits significantly affected the Firmicutes to Bacteroidetes ratio. We 
conclude that the choice of DNA isolation and sampling kit (dilution step, and by extension the stool consistency) 
is an important batch effect that has to be taken into account mainly when comparing results between studies.
Methods
Sample collection. Stool samples were collected from a group of 16 volunteers. The subjects were 23–65 
years old with an average age of 40.9 and none of them suffered from diarrhea during sample collection. Stool 
samples were collected at home. Volunteers received three stool sampling kits: sampling kit 1 (SK1) comprising 1x 
stool container (FL Medical, Italy); sampling kit 2 (SK2) comprising 2x flocked swabs (Copan, Italy) and sampling 
kit 3 (SK3) comprising 2x cotton swabs (SceneSafe, Great Britain). Sampling kits also contained disposable gloves 
and hand and surface disinfectant wipes for more convenient sampling. Each volunteer was instructed to collect 
all the samples from the same stool and from the same spot. Stool samples were then stored in a freezer at −20 °C 
overnight to freeze completely and the next day were transported on ice buckets to the laboratory, where they 
were stored at −20 °C prior to processing. Each group of samples was processed at the same time and by the same 
person. Participants filled out a brief questionnaire about satisfaction with individual sampling kits after stool 
sample collection. The study design is summarized in Fig. 6.
This study was carried out in accordance with the recommendations of the ELSPAC Steering Committee of 
Masaryk University with written informed consent from all subjects. All subjects gave written informed consent 
in accordance with the Declaration of Helsinki. The protocols were approved by the ELSPAC Steering Committee 
of Masaryk University.
DNA extraction. Stool in the stool container (SK1) was diluted 5x with molecular grade water and homoge-
nized by vortexing with Zirconia beads 2.3 mm (BioSpec, USA) to receive identical aliquots. This step is not neces-
sary for the swabs, since each swab serves as an aliquot itself. Stool suspension (250 µl) was used for DNA extractions. 
Flocked swabs (SK2) and cotton swabs (SK3) were transferred into 2 ml tubes to be prepared for subsequent DNA 
extraction. DNA extractions were performed using a PowerLyzer PowerSoil DNA Isolation Kit (Mo Bio, USA) (PS) 
and QIAamp DNA Stool Mini Kit (Qiagen, USA) (QS) according to the manufacturer’s instructions.
Deviations from PS protocol:
•	 750 µl of Bead Solution and 60 µl of C1 Solution were added to swab samples (SK2 and SK3) after defrosting. 
Samples were thoroughly vortexed and centrifuged for 4 min at 36,220 RCF. The swabs were then removed. 
Next, the samples were homogenized using the FastPrep-24 (MP Biomedicals, USA) 45 s 6.5 m/s.
Deviations from QS protocol:
•	 A homogenization step with 0.1 mm zirconia beads (BioSpec, USA) was added to the protocol after the third 
step (i.e. after the suspension was heated for 5 min at 95 °C).
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•	 1.4 µl Buffer ASL was added to swab samples (SK2 and SK3) after defrosting. Samples were vortexed continu-
ously for 1 min and the suspension was heated for 5 min at 70 °C. Next, the samples were homogenized using 
the FastPrep-24 (MP Biomedicals, USA) 45 s 5.5 m/s.
Evaluation of DNA yield, purity and quality. The final yield of extracted DNA was determined spec-
trophotometrically using theNanoDropND-1000 (Thermo Fisher SCIENTIFIC, USA). The purity of extracted 
DNA was indicated by an A260/A280 nm ratio. The quality of extracted DNA was assessed using the Fragment 
Analyzer (Advanced Analytical Technologies, USA) and High Sensitivity Genomic DNA Analysis Kit (Advanced 
Analytical Technologies, USA). The percentage of short fragments (≤1,500 bp) and Genomic Quality Number 
(GQN threshold of 10,000 bp) were calculated by PROSize 2.0 (Advanced Analytical Technologies, USA). 
Extracted DNA from each sample was diluted approximately to 5 ng/µl, aliquoted and stored at −20 °C. Aliquots 
were subsequently used in all further methods as starting material.
Presence of PCR inhibitors after different DNA extractions. The presence of inhibitors was tested by 
qPCR. A primer pair specific for the conservative regions of 16S rRNA gene (Table 3) was used. qPCR was per-
formed on the TOptical Thermocycler (Analytik Jena - Biometra, Ireland) using a KAPA SYBR FAST qPCR Kit 
(Kapa Biosystems, USA). Cycling conditions are described in Table 2. Melting temperature was determined after 
PCR to verify the correctness of each PCR product. Extracted DNA from four different isolates of Escherichia 
coli DH10B served as a positive control without PCR inhibitors. Each extracted DNA from sample and positive 
control (concentration approximately 5 ng/µl) was diluted three times (10x, 100x, 1,000x). The subsequent qPCR 
reactions were performed using both diluted and undiluted samples. Inhibition plots were created from Ct values 
and efficiency (=10(−1/slope)−1) was calculated for each sample and positive control.
Proportion of human DNA to bacterial DNA after different DNA extractions. The ratio of human 
and bacterial DNA in samples was tested by qPCR. Bacterial DNA was assessed using a primer pair specific 
for the conservative regions of 16S rRNA gene and human DNA using a primer pair specific for protein kinase 
(Table 3). qPCRwas performed on the TOptical Thermocycler (Analytik Jena - Biometra, Ireland) with KAPA 
SYBR FAST qPCR Kit (Kapa Biosystems, USA). Cycling conditions are described in Table 3. Melting temperature 
Figure 6. Study design. Flowchart summarizing the study design and methods used.
Target region/gene
Amplicon 
size Primer name Primer Sequences (5′ → 3′) Cycling conditions Reference
16S rRNA gene 
(bacterial DNA) 146 bp
q16S-univF GTGSTGCAYGGYTGTCGTCA 95 °C 45x 95 °C 53 °C 72 °C
Maeda et al.90
q16S-univR ACGTCRTCCMCACCTTCCTC 10 min 20 s 30 s 20 s —
GAPDH (human 
DNA) 74 bp
TGCACCACCAACTGCTTAGC 95 °C 40x 95 °C 65 °C Vandesompele 
et al.91GGCATGGACTGTGGTCATGAG 10 min 10 s 60 s — —
V3/V4 16S rRNA gene 
(library preparation) ~460 bp
s16S_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-InnerTag-CCTACGGGNGGCWGCAG 95 °C 25x 95 °C 55 °C 72 °C 72 °C Klindworth 
et al.79
s16S_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG- InnerTag-GACTACHVGGGTATCTAATCC 3 min 30 s 30 s 30 s 5 min
Table 3. Primers and cycling conditions used in this study.
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was determined after PCR to verify the correctness of each PCR product. The amount of human DNA to bacterial 
DNA was calculated as 2ΔCt. Ct value of 40 was used for all samples under the limit of detection.
PCR amplification and Illumina library preparation. Extracted DNA was used as a template in ampli-
con PCR to target the hypervariable V3 and V4 regions of the bacterial 16S rRNA gene. The 16S metagenom-
ics library was prepared according to the Illumina 16S Metagenomic sequencing Library Preparation protocol 
with some deviations described below (for workflow diagram see Supplementary Fig. S1). Each PCR was per-
formed in triplicate, with the primer pair consisting of Illumina overhang nucleotide sequences, an inner tag and 
gene-specific sequences79. The Illumina overhang served to ligate the Illumina index and adapter. Each inner tag, 
i.e. a unique sequence of 7–9 bp, was designed to differentiate samples into groups. Primer sequences and PCR 
cycling conditions are summarized in Table 3. After PCR amplification, triplicates were pooled and the amplified 
PCR products were determined by gel electrophoresis. PCR clean-up was performed with Agencourt AMPure 
XP beads (Beckman Coulter Genomics, USA). Samples with different inner tags were equimolarly pooled based 
on fluorometrically measured concentration using Qubit dsDNA HS Assay Kit (Invitrogen, USA) and microplate 
reader Synergy Mx (BioTek, USA). Pools were used as a template for a second PCR with Nextera XT indexes 
(Illumina, USA). Differently indexed samples were quantified using the KAPA Library Quantification Complete 
Kit (Kapa Biosystems, USA) and equimolarly pooled according to the measured concentration. The prepared 
library was checked with a 2100 Bioanalyzer Instrument (Agilent Technologies, USA) and concentration was 
measured with qPCR shortly before sequencing. The library was diluted to a final concentration of 8 pM and 
20% of PhiX DNA (Illumina, USA) was added. Sequencing was performed with the Miseq reagent kit V3 using a 
MiSeq. 2000 instrument according to the manufacturer’s instructions (Illumina, USA).
Data analysis. Forward and reverse pair-end reads, that fulfilled the condition of both quality and length fil-
tering, were merged using the fastq-join method within the join_pair_ends.py command in QIIME 1.9.180. Data 
were demultiplexed and barcodes and primers were trimmed using package Biostrings81 in R 3.3.282. Operational 
taxonomic units (OTUs) were constructed by binding sequences into clusters of greater than 97% sequence sim-
ilarity using QIIME. In the next step, chimeras were detected on the set of representative sequences of each OTU 
with UCHIME in USEARCH v6.1.54483. These chimera OTUs were subsequently excluded from the analysis. 
Taxonomy was assigned to each OTU based on SILVA 123 reference database84. The observed species metric and 
the Chao1 index were used to estimate alpha diversity for each sample in QIIME. Beta diversity was computed in 
QIIME using both weighted and unweighted UniFrac metrics85. All statistical analysis was performed in R 3.3.282.
The data were treated as compositional (proportions of total read count in each sample, non-rarefied) and 
prior to all statistical analyses were transformed using centered log-ratio transformation86. The analyses were per-
formed on each of the seven taxonomy levels (Phylum, Class, Order, Family, Genus, Species and OTUs) separately 
and the resulting p-values were adjusted for multiple hypothesis testing using Benjamini-Hochberg procedure. 
Results were considered significant at FDR = 10%. The adjusted p-values are referred to as q-values.
To estimate the effects of isolation and sampling kits on bacterial composition while accounting for repeated 
measurements (effect of individual), we applied linear mixed model with sampling and izolation kits as fixed 
effects and individual as random effect (intercept). Log-likelihood test was performed to detect significance of 
each of the fixed effects – each time we compared the full model to the model without the fixed effect of interest.
A non-parametric Wilcoxon paired test, was used for comparison of effect of isolation kits on DNA quality. 
We used Spearman’s rank order correlation coefficient to discover the strength of the link between the number of 
observed species and DNA concentration.
Bipartite networks were used to visualize the influence of different kits on detection of Gram-positive and 
Gram-negative bacteria. These networks were reconstructed according to Sedlar et al.87 using R 3.3.2 and visual-
ized in Gephi 0.9.288,89. Communities within networks were extracted using modularity optimization criterion88.
Data Availability
Sequencing data were uploaded to the European Nucleotide Archive under accession number PRJEB24411. Read 
counts per sample at different taxa levels and sample information table are available in Supplementary Files S9–
S11.
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